Keywords
miscarriage
preterm delivery
placental dysfunction
placental growth factor
pre-eclampsia
How to Cite
Abstract
To assess the role of the placental growth factor in the development of gestational complications during multiple pregnancy, there was conducted a study of this indicator in serum of 320 pregnant women with multiple pregnancy in the first trimester and 40 pregnant women with singleton pregnancy (the control group).
The objective of the research was to study the effect of placental growth factors on the gestational process in multiple pregnancy.
Materials and Methods. There was conducted a prospective study of pregnancy and childbirth in 320 females with multiple pregnancy (the main group) and 40 healthy women with singleton pregnancy. The level of serum placental growth factor was determined by enzyme-linked immunosorbent assay using monoclonal antibodies in the first trimester of pregnancy. The indicators of the hemostasis system (vascular, platelet and coagulation components) were evaluated according to generally accepted methods. Doppler ultrasound of the placental and fetal blood flow was performed in the uterine arteries, the umbilical artery and vein, the fetal middle cerebral artery.
Results. Women with multiple pregnancy were at high risk of developing gestational complications such as preterm deliveries (67.8%, p<0.01), placental dysfunction, pre-eclampsia (17.5%, p<0.05). The disorders of the vascular platelet and coagulation hemostasis in the first trimester of pregnancy were the main risk factors for early termination of pregnancy. Low level of serum placental growth factor in pregnant women with multiple pregnancy in case of preterm delivery, placental dysfunction and pre-eclampsia (111.23 ± 8.4, 203.24 ± 6.4 and 305.86 ± 7.4 pg/ml), in comparison with the corresponding indicators in singleton pregnancy (418.2 ± 10.4 pg/ml), was proven to be a prognostic marker for the development of gestational complications.
Conclusions. Timely correction of gestational complications in multiple pregnancy with micronized progesterone, low molecular weight heparins, angio-protective agents allowed us to prolong pregnancy with monochorionic placentation type for 3.2 weeks (up to 34.2 ± 2.4 weeks) and provide full-time delivery of dichorionic twin pregnancy.
References
Baranov II, Tokova ZZ, Tadevosian AA. Perinatalnye iskhody pri mnogoplodnykh rodakh. Obstetrics and Gynecology. 2012;1:98-102.
Vdovychenko YuP. Bahatoplidna vahitnist: navchalnyi posibnyk. Ch. II (dlia vykladacha). Kyiv; c2011. 360p.
Krasnopolskiy VI, Novikova SV, Kapustina MV et al. Sovremennye problemy mnogoplodnoy beremennosti. Russian Bulletin of Obstetrician-Gynecologist. 2009;2:79-81.
Botting BJ, MacDonald-Davies I, Macfarlane AJ. Recent trends in the incidence of multiple birth and associated mortality. Arch Dis Child. 1987;62(9):941-950. DOI: https://doi.org/10.1136/adc.62.9.941 [PMid:3674947 PMCid:PMC1778571]
Nikitina I, Boychuk A, Babar T et al. Prediction of threats to multiple pregnancy interruption depending on the cause of its occurrence. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2016;7(5):764-771.
Nikitina I, Boychuk A, Kalashnik N et al. Immunomorphological features of the placenta in multiple pregnancies. Georgian Medical News. 2016;6(255):12-17.
Almonte L, Davis M, Ward C et al. Spontaneous and non-spontaneous twins: a comparison study of preterm labor, preterm premature rupture of membranes, gestational age at delivery, maternal age, and length of hospital stay. Twin Research and Human Genetics. 2012;15(2):170.
Hassan SS, Romero R, Vidyadhari D et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011;38(1):18-31. DOI: https://doi.org/10.1002/uog.9017 [PMid:21472815 PMCid:PMC3482512]
American College of Obstetricians and Gynecologists, Committee on Practice Bulletins-Obstetrics. ACOG practice bulletin no. 127: Management of preterm labor. Obstet Gynecol. 2012;119(6):1308-1317. DOI: https://doi.org/10.1097/AOG.0b013e31825af2f0 [PMid:22617615]
Romero R, Nicolaides K, Conde-Agudelo A et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol. 2012;206(2):124.e1-19. DOI: https://doi.org/10.1016/j.ajog.2011.12.003 [PMid:22284156 PMCid:PMC3437773]
Salazar EL, Calzada L. The role of progesterone in endometrial estradiol and progesterone-receptor synthesis in women with menstrual disorders and habitual abortion. Gynecol Endocrinol. 2007;23(4):222-225. DOI: https://doi.org/10.1080/09513590701254030 [PMid:17505942]
Maruo T, Murata K, Matsuo H et al. Insulin-like growth factor-I as a local regulator of proliferation and differentiated function of the human trophoblast in early pregnancy. Early Pregnancy. 1995;1(1):54-61.
Shore VN, Wang TN, Wang TL et al. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta. 1997;18(8):657-665. DOI: https://doi.org/10.1016/S0143-4004(97)90007-2
Boiko VI, Nikitina IM, Babar TV et al. The problem of miscarriage in multiple pregnancy. Wiadomości Lekarskie. 2018;LXXI(7):1195-1199.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.